Piperacillin Sodium And Tazobactam Sodium Injection, Powder, Lyophilized, For Solution
NDC Package 22607-034-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Piperacillin Sodium And Tazobactam Sodium injection is a human prescription drug. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Mitim S.r.l., this product is identified by NDC 22607-034.

Identification & Billing

NDC Package Code
22607-034-02
Package Description
16 CARTON in 1 BOX / 10 VIAL, SINGLE-USE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-USE
Product Code
22607-034
11-Digit Billing Format
22607003402

Clinical Specifications

Proprietary Name
Piperacillin Sodium And Tazobactam Sodium
Non-Proprietary Name
Piperacillin Sodium And Tazobactam Sodium
Substance Name
Piperacillin Sodium; Tazobactam Sodium
Dosage Form
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Mitim S.r.l.
Product Type
Human Prescription Drug
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
03-22-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 22607-034-02 identifies a specific commercial package of 16 carton in 1 box / 10 vial, single-use in 1 carton / 10 ml in 1 vial, single-use of Piperacillin Sodium And Tazobactam Sodium (UNFINISHED drug), a human prescription drug labeled by Mitim S.r.l.. This injection, powder, lyophilized, for solution is formulated for use and contains piperacillin sodium; tazobactam sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mitim S.r.l. on March 22, 2017. The current certification is valid through December 31, 2026.

How is this Mitim S.r.l. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 22607003402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
22607-034-02
11-Digit CMS (5-4-2)
22607-0034-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.